ArabFinance: Memphis Pharmaceutical (MPCI) extraordinary general meeting (EGM) approved setting the authorized capital at EGP 300 million instead of EGP 100 million in its articles of association, according to the company’s October 4th statement filed to the Egyptian Exchange.
The EGM approved amending article no. 6 of articles of association.
The company posted a net profit before taxes of EGP 2.920 million in July-August period for the fiscal year 2020/2021, a 143% rise from EGP 1.200 million achieved in the prior-year period.
Memphis Company is one of the companies of the drug holding company in Egypt. Memphis Company is considered one of the oldest pharmaceutical and chemical companies in the Middle East since 1940.
Copyright © 2020 Arab Finance Brokerage Company All rights reserved. Provided by SyndiGate Media Inc. (Syndigate.info).
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.
